Researchers from Stanford have developed a wearable sensor to monitor the size of tumors, which could assist new cancer drug evaluations.
Researchers are harnessing an imaging technique called cryogenic electron microscopy to design drugs and better understand disease.
Stanford Medicine magazine explores the molecules behind human biology and how understanding them fuels medical discoveries and innovations.
Researchers at Stanford Medicine are working to develop antivirals to stop the current pandemic and prevent ones.
Researchers discuss the need for ethics and its integration into research projects that harness artificial intelligence.
To help us understand muscle loss as we age, a Stanford Medicine research team’s engineered tissue is sent to the International Space Station.
Anthony Oro is devoted to understanding the origin of basal cell carcinomas. Now he's found how some become resistant to a common treatment.
Stanford Medicine researchers have discovered a drug that could potentially be used to stave off SARS-CoV-2, the virus that causes COVID-19.
The Innovative Medicines Accelerator builds on existing programs at Stanford — but fills in gaps to help researchers turn ideas into drugs.
A study provides evidence that the drug azlocillin eliminates the bacteria that cause Lyme disease at the onset of infection in lab mice and cultures.
An antibody against the "don't eat me" signal on cancer cells appears safe and well-tolerated by patients with advanced cancers. A phase 2 trial is planned.
Stanford researchers have discovered a compound that reduces the symptoms of heart failure after a heart attack in initial animal tests.
A Stanford professor unpacks some of the dynamics of the current drug pricing system and the potential effects of other approaches to this market.
Stanford chemists have developed a potential new strategy for fighting antibiotic-resistant bacterium — adding a new molecule onto an existing antibiotic.
Stanford researchers have identified a small molecule that may help curb some of the symptoms of a genetic deficiency in glucose-6-phosphate dehydrogenase.
As someone who had spent her career studying molecules on a computer screen, experiments involving people were a revelation and inspiration for Jane Tseng, PhD, …